Stock Events

Orion 

$45.54
65
+$0+0% Monday 14:46

Statistics

Day High
47.16
Day Low
47.16
52W High
47.16
52W Low
37
Volume
629
Avg. Volume
0
Mkt Cap
5.09B
P/E Ratio
0
Dividend Yield
3.87%
Dividend
1.76

Upcoming

Dividends

3.87%Dividend Yield
10Y Growth
0.25%
5Y Growth
0.86%
3Y Growth
-0.14%
1Y Growth
1.62%

Earnings

24JulConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Next
-0.19
0.41
1.01
1.61
Expected EPS
-0.01632855
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORINF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Fluor
FLR
Mkt Cap8.16B
Fluor Corporation is a global engineering and construction firm, directly competing with Orion in the heavy civil and marine construction sectors.
Quanta Services
PWR
Mkt Cap39.35B
Quanta Services provides infrastructure solutions for the electric power, pipeline, industrial, and communications industries, overlapping with Orion's services in utility and marine construction.
KBR
KBR
Mkt Cap8.77B
KBR, Inc. is a global provider of differentiated professional services and technologies across the asset and program life cycle within the government services and hydrocarbons sectors, competing with Orion in engineering and construction services.
Mastec
MTZ
Mkt Cap8.55B
MasTec, Inc. is an infrastructure construction company operating mainly in the utility, energy, and communication sectors, competing with Orion in utility and marine construction projects.
Dycom Industries
DY
Mkt Cap5.21B
Dycom Industries, Inc. provides specialty contracting services throughout the United States and in Canada, including for the construction and maintenance of telecommunications infrastructure, competing with Orion in the utility construction sector.
Emcor
EME
Mkt Cap17.69B
EMCOR Group, Inc. is a leader in mechanical and electrical construction, industrial and energy infrastructure, and building services, competing with Orion in the construction and maintenance of critical infrastructure.
Granite Construction
GVA
Mkt Cap2.79B
Granite Construction Incorporated is a diversified construction and construction materials company, directly competing with Orion in civil construction and materials.
Tetra Tech
TTEK
Mkt Cap10.89B
Tetra Tech, Inc. provides consulting, engineering, program management, construction management, and technical services worldwide, competing with Orion in engineering and project management services.
AECOM
ACM
Mkt Cap11.86B
AECOM is a global network of experts working with clients, communities, and colleagues to develop and implement innovative solutions to the world’s most complex challenges, including competing with Orion in construction and engineering services.

About

Pharmaceuticals: Major
Health Technology
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan for Parkinson's disease; Simdax for acute decompensated heart failure; and Fareston for breast cancer, as well as Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. The company also offers veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; and APIs for generic and proprietary drugs, as well as provides contract manufacturing services. In addition, it markets and sells veterinary drugs manufactured by other international companies. The company serves various healthcare service providers and professionals, such as specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories, as well as consumers with pets. Orion Oyj has partnership with Propeller Health to connect the Easyhaler(R) product portfolio for the treatment of asthma and COPD; and a research collaboration and license agreement with Alligator Bioscience AB (publ) to discover and develop new bispecific antibody cancer therapeutics. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Show more...
CEO
Employees
3698
Country
FI
ISIN
FI0009014377
WKN
000A0J3QM

Listings